[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342002-105":59,"doc-detail-342002-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","rabenosyn-5-suppresses-non-small-cell-lung-cancer-metastasis-via-inhibiting-cdc42-activity","Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity","","Rabenosyn-5 (Rbsn) is identified as an inhibitor of filopodia formation and non-small cell lung cancer metastasis. Mechanistically, Rbsn interacts with CDC42 and acts as a GTPase activating protein (GAP), suppressing CDC42 activity and the resulting filopodia formation. Akt phosphorylates Rbsn at Thr253, and this phosphorylation abolishes Rbsn’s inhibitory effect on CDC42. Rbsn expression is downregulated in lung cancer and correlates with worse prognosis, supporting its role in limiting cancer progression through metastasis suppression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rabenosyn-5-suppresses-non-small-cell-lung-cancer-metastasis-via-inhibiting-cdc42-activity/342002/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rabenosyn-5-suppresses-non-small-cell-lung-cancer-metastasis-via-inhibiting-cdc42-activity/342002.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does Rabenosyn-5 (Rbsn) play in non-small cell lung cancer metastasis?","Question",{"text":113,"@type":114},"Rbsn suppresses filopodia formation and inhibits lung cancer metastasis. The study shows it limits metastatic progression by restraining CDC42 activity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does Rbsn affect CDC42 at the molecular level?",{"text":118,"@type":114},"Rbsn interacts with CDC42 and functions as a GTPase activating protein (GAP). This decreases CDC42 activity, thereby blocking downstream filopodia formation.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the impact of Akt phosphorylation on Rbsn’s function?",{"text":122,"@type":114},"Akt phosphorylates Rbsn at the Thr253 site, and this phosphorylation negates Rbsn’s inhibitory effect on CDC42 activity. As a result, the suppression of filopodia formation is reduced.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},342002,1790844371,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer Gene [Therapy](Therapy www.nature.com/cgt)[ www.nature.com/cgt](Therapy www.nature.com/cgt)  \nARTICLE OPEN   \nRabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity  \n 1, Bin Mu2, Lin Zhu3,4, Yanli Zhuo5, Ping Mu 4,6 ✉, Fu Ren 4,7 ✉ and Fangjin Lu 8,9 ✉  \nXiong Guo  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Metastasis, the primary cause of death in lung cancer patients, is facilitated by cytoskeleton remodeling, which plays a crucial role in cancer cell migration and invasion. However, the precise regulatory mechanisms of intracellular trafﬁcking proteins involved in cytoskeleton remodeling remain unclear. In this study, we have identiﬁed Rabenosyn-5 (Rbsn) as an inhibitor of ﬁlopodia formation and lung cancer metastasis. Mechanistically, Rbsn interacts with CDC42 and functions as a GTPase activating protein (GAP), thereby inhibiting CDC42 activity and subsequent ﬁlopodia formation. Furthermore, we have discovered that Akt phosphorylates Rbsn atthe Thr253 site, and this phosphorylation negates the inhibitory effect of Rbsn on CDC42 activity. Additionally, our analysis reveals that Rbsn expression is signiﬁcantly downregulated in lung cancer, and this decrease is associated with a worse prognosis. These ﬁndings provide strong evidence supporting the role of Rbsn in suppressing lung cancer progression through the inhibition of |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| metastasis. |  |  |\n|  | Cancer Gene Therapy (2024) 31:1465–1476; [https://doi.org/10.1038/s41417-024-00813-4](https://doi.org/10.1038/s41417-024-00813-4) |  |\n|  |  |  |\n\nBACKGROUND  \nNon-small cell lung cancer (NSCLC) represents a grave concern for public health, leading the spectrum of malignancies in both incidence and mortality [1, 2] . Due to the signiﬁcant advancements in targeted therapy and immunotherapy in recent years, the survival of NSCLC patients has improved [3] . Nevertheless, a substantial subset of patients is diagnosed at an advanced stage, with metastases already present [4] . The metastasis of lung cancer impacts the quality of life of patients, and results in the leading cause of death [5, 6] . Consequently, an in-depth exploration of the molecular mechanisms underlying NSCLC metastasis is imperative. This research is pivotal for identifying novel therapeutic targetsand developing innovative pharmacological strategies, thereby enhancing treatment outcomes for patients with NSCLC.  \nCytoskeletal remodeling is a pivotal process in cancer cell metastasis, with small Rho GTPases acting as key regulators. Among these, Rac, cell division cycle protein 42 (CDC42), and Rho are extensively characterized for their distinct roles in cytoskeletal dynamics. Rac activation is associated with the generation of lamellipodia and membrane rufﬂes, CDC42 activation promotes ﬁlopodia assembly, and Rho activation is linked to the formation of stress ﬁbers [7, 8] . These small Rho GTPases have garnered attention as critical targets in anticancer therapy due to their central roles in modulating cytoskeletal dynamics, which is fundamental to cancer metastasis. They facilitate metastatic spread by not only driving the migratory and invasive capabilities of cancer cells [9–11] but also by  \naugmenting the migration of endothelial cells, a process essential for angiogenesis [12–14] .  \nRho GTPase proteins exhibit activity when localized at the plasma membrane or endomembrane (e.g., endosomes, Golgi)  \n[15] . The intracellular trafﬁcking of these proteins plays a crucial role in their cellular functions by inﬂuencing their subcellular distribution. For instance, Arf6-mediated membrane trafﬁcking can modulate the localization and activation of CDC42, thereby impacting CDC42-driven cell migration [16] . Additionally, Rab5, a key regulator of endocytosis, has been shown to activate Rac and promote lamellipodia formation by facilitating the trafﬁcking of Rac to th","cbCailA2Y56beoEk","https://ap.wps.com/l/cbCailA2Y56beoEk","pdf",5625429,12,"English","# Background\n## Non-small cell lung cancer and metastasis significance\n## Cytoskeletal remodeling and Rho GTPases in invasion and migration\n## Intracellular trafficking pathways regulating small GTPase activity\n# Study focus and rationale\n## Role of Rabenosyn-5 (Rbsn) in Rab4/Rab5 signaling\n## Open question on direct interaction with small Rho GTPases","[{\"question\":\"What role does Rabenosyn-5 (Rbsn) play in non-small cell lung cancer metastasis?\",\"answer\":\"Rbsn suppresses filopodia formation and inhibits lung cancer metastasis. The study shows it limits metastatic progression by restraining CDC42 activity.\"},{\"question\":\"How does Rbsn affect CDC42 at the molecular level?\",\"answer\":\"Rbsn interacts with CDC42 and functions as a GTPase activating protein (GAP). This decreases CDC42 activity, thereby blocking downstream filopodia formation.\"},{\"question\":\"What is the impact of Akt phosphorylation on Rbsn’s function?\",\"answer\":\"Akt phosphorylates Rbsn at the Thr253 site, and this phosphorylation negates Rbsn’s inhibitory effect on CDC42 activity. As a result, the suppression of filopodia formation is reduced.\"}]","Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity | PDF",1790044708,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/758ec127306bc6b7681b0efc71624065.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/465d2db1bcca22c406d3d1873e283782.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6a6fd12afdaf9fa6d4a780746149bdc.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/add84a5cbe12130454066ec8feac912b.webp",980,1301]